COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Periodontal Disease and Cardiovascular Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00763165
Recruitment Status : Unknown
Verified September 2008 by Colgate Palmolive.
Recruitment status was:  Active, not recruiting
First Posted : September 30, 2008
Last Update Posted : October 2, 2008
Information provided by:
Colgate Palmolive

Brief Summary:
To access the influence of triclosan dentifrice on the progression of periodontal disease in patients with coronary heart disease.

Condition or disease Intervention/treatment Phase
Periodontal Diseases Drug: Triclosan Drug: Fluoride Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 438 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Periodontal Disease and Cardiovascular Disease
Study Start Date : November 2000
Estimated Primary Completion Date : December 2009
Estimated Study Completion Date : December 2009

Arm Intervention/treatment
Active Comparator: A Drug: Triclosan
Brush twice daily

Drug: Fluoride
Brush twice daily

Placebo Comparator: B Drug: Fluoride
Brush twice daily

Primary Outcome Measures :
  1. Periodontal disease [ Time Frame: 3-5 Years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • A minimum of 12 uncrowned teeth other than 3rd molars
  • Age 18 to 75 years
  • Informed consent

Exclusion Criteria:

  • Prosthetic heart valves
  • Prosthetic joint replacement
  • Previous infective endocarditis
  • Requirement for antibiotic cover for dental treatment
  • Current treatment with warfarin

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00763165

Layout table for location information
Discipline of Medicine
Chermside, Australia
Sponsors and Collaborators
Colgate Palmolive
Layout table for investigator information
Principal Investigator: Gregory Seymour, BDS
Layout table for additonal information
Responsible Party: William DeVizio/VP - Clinical Research, Colgate Palmolive Identifier: NCT00763165    
Other Study ID Numbers: D/06/Dent/99
First Posted: September 30, 2008    Key Record Dates
Last Update Posted: October 2, 2008
Last Verified: September 2008
Additional relevant MeSH terms:
Layout table for MeSH terms
Periodontal Diseases
Cardiovascular Diseases
Mouth Diseases
Stomatognathic Diseases
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs
Anti-Infective Agents, Local
Anti-Infective Agents
Fatty Acid Synthesis Inhibitors
Hypolipidemic Agents
Molecular Mechanisms of Pharmacological Action
Lipid Regulating Agents